Article
MicroRNA-21 drives the switch to a synthetic phenotype in human saphenous vein smooth muscle cells.
IUBMB life - 1 Jul 2018
Alshanwani Aliah R, Riches-Suman Kirsten, O'Regan David J, Wood Ian C, Turner Neil A, Porter Karen E
Abstract excerpt
Cardiovascular disease is a leading cause of morbidity and mortality. Smooth muscle cells (SMC) comprising the vascular wall can switch phenotypes from contractile to synthetic, which can promote the development of aberrant remodelling and intimal hyperplasia (IH). MicroRNA-21 (miR-21) is a short, non-coding RNA that has been implicated in cardiovascular diseases including proliferative vascular disease and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
